头颈癌原发放疗后孤立区域复发的结局分析
复发后2年生存率为40%,总生存与挽救手术切缘状态及结外扩散(ENS)相关,p16阳性口咽鳞癌与更好总生存相关。
要点
- 孤立区域复发率5.2%,84%可接受挽救手术。
- 复发后2年生存率40%,长期生存可能。
- 切缘阴性、无ENS、p16阳性者预后更好。
核心结论
- 头颈鳞癌孤立区域复发后长期生存可能,p16阳性口咽鳞癌、挽救手术完全切除及无结外扩散与更好结局相关。
研究设计与样本
- 回顾性队列研究,纳入2007至2017年接受根治性放疗的1811例头颈鳞癌患者,识别孤立颈部淋巴结复发,采用单因素和多因素分析生存及第二复发相关因素。
主要发现
- 孤立区域复发后2年生存率为40%。
- 总生存和第二复发时间与挽救手术切缘状态及结外扩散(ENS)相关。
- p16阳性口咽鳞癌与更好总生存相关。
关键数值与推荐
- 孤立区域复发率5.2%(95/1811)。
- 复发后2年生存率40%。
临床怎么用
- 对头颈鳞癌放疗后孤立区域复发患者,应评估挽救手术可行性,争取完全切除;p16状态和ENS有助于预后分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Isolated regional recurrences following head-neck squamous-cell carcinomas (HNSCC) are often accessible for curatively intended salvage treatment. Factors prognostic for outcome were investigated in a large cohort of HNSCC patients. METHODS: In total, 1811 patients receiving curatively intended radiotherapy from 2007 to 2017 were reviewed and isolated cervical nodal recurrences were identified. Factors associated with survival and second recurrence were investigated using univariate and multivariate analyses. RESULTS: Isolated regional recurrence was seen in 95/1811 (5.2%) patients. Eighty of 95 patients (84%) received salvage surgery. Two-year survival after isolated regional recurrence was 40%. Overall survival (OS) and time to second recurrence were associated with resection status of the salvage surgery and presence of extranodal spread (ENS), while p16-positive oropharyngeal squamous-cell carcinoma (OPSCC) was associated with better OS. CONCLUSION: Long-term survival after regional recurrence in HNSCC is possible. p16-positive OPSCC, complete salvage surgery, and lack of ENS are associated with better outcome.
引用
- Lindegaard AM, von Buchwald C, Rasmussen JH, et al. Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer. Head Neck. 2020. PMID: 32681703. doi:10.1002/hed.26361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。